Genovis: Signs Service Agreement With evitria AG – Expands Into a New Business Area - Redeye

Redeye endorses Genovis entering into a service agreement with evitria AG for LC-MS analysis of recombinant antibodies. We see the agreement as yet another proof of the broad applicability of Genovis’ enzymes and continue to see the stock as a compelling investment for the long-term investor.

Länk till analysen i sin helhet: https://www.redeye.se/research/850041/genovis-signs-service-agreement-with-evitria-ag-expands-into-a-new-business-area?utm_source=finwire&utm_medium=RSS